bluebird bio, Inc.
BLUEDelisted Jun 2, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001293971
bluebird bio, Inc. was delisted on Jun 2, 2025; its insiders filed their last Form 4 on Jun 3, 2025; 85 institutions reported holding it in 13F filings for Q1 2025, worth $17.1M in total; no superinvestor held it.
Q2 2025 vs. Q1 2025
How the institutions holding bluebird bio, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 85 | 1 | 3 | −81 |
| Shares | 3.50M | 33 | 1.39K | −3.50M (−100.0%) |
| Value | $17.1M | $162 | $6.89K | −$17.1M (−100.0%) |
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (1)
Institutions that held bluebird bio, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| IFP Advisors, Inc | 7 | $3 | 0.00% |
Sold out (82)
Institutions that held bluebird bio, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
Not filed for Q2 2025 yet (1)
Institutions that held bluebird bio, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Sandy Spring Bank | 33 | $162 |